Transform Therapies, Reimagine Lives.
Transforming the lives of patients living with immune-mediated diseases using a precision approach to develop oral therapies.
News
May 13,
2025
Alumis Stockholders Approve Merger with ACELYRIN
April 21,
2025
Alumis and ACELYRIN Announce Amended Merger Agreement